Joint efforts will demonstrate the clinical utility of the Verita ™ exosome enrichment platform and ExoVita ™ Pancreas Assay to improve early detection of pancreatic cancer SAN DIEGO--(BUSINESS WIRE)- ...

SAN DIEGO--(BUSINESS WIRE)--Biological Dynamics, Inc., a leader in exosome-isolation technology for early disease detection, today announced that its ExoLuminate Study is expanding subject enrollment ...

Biological Dynamics CEO Raj Krishnan and CFO Kevin Han shared what informs their vision for developing liquid biopsies to detect cancer at the earliest stages to ensure the best outcome for patients.

San Diego-based Biological Dynamics has received a $1 million follow-on grant from the Bill & Melinda Gates Foundation to continue work on a novel tuberculosis diagnostics system targeting countries ...

Raj Krishnan grew up in the San Francisco Bay Area in the 1990s, a time when “you could throw an idea against the wall and somebody would give you $30 million to build something.” But when it came ...

Biological Dynamics Inc.’s Verita platform correctly identified 96% of patients with stage I pancreatic cancer, a study in Nature Communications Medicine demonstrated. The platform uses protein ...

Biological Dynamics is a private molecular diagnostics company that develops novel technologies for the isolation and analysis of rare cells and nucleic acids from biological samples. The company's ...